BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7705312)

  • 1. Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.
    Torphy TJ; Barnette MS; Hay DW; Underwood DC
    Environ Health Perspect; 1994 Dec; 102 Suppl 10(Suppl 10):79-84. PubMed ID: 7705312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
    Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
    J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
    Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
    Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
    Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
    Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs.
    Manabe H; Akuta K; Okamura K; Ohmori K
    Int Arch Allergy Immunol; 1997 Dec; 114(4):389-99. PubMed ID: 9414145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
    Souness JE; Scott LC
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL; Conanan ND
    J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
    Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.
    Souness JE; Carter CM; Diocee BK; Hassall GA; Wood LJ; Turner NC
    Biochem Pharmacol; 1991 Jul; 42(4):937-45. PubMed ID: 1651083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
    Turner NC; Lamb J; Worby A; Murray KJ
    Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
    Grous M; Barnette M
    Br J Pharmacol; 1994 Jan; 111(1):259-63. PubMed ID: 7516803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
    Ortiz JL; Vallés JM; Martí-Cabrera M; Cortijo J; Morcillo EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):200-6. PubMed ID: 8717161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.